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MuLV-induced myeloid leukemias (MML) having promonocytic characteristics are produced with high incidence in some
strains of adult mice that are undergoing chronic peritoneal inflammation. Previously we showed that many leukemias have
rearrangements of the c-myb locus due to insertional mutagenesis, however, we also identified a number of leukemias that
had proviral integrations in the absence of c-myb rearrangement. In the present study, a new locus, Mml1, was found to
be a target of insertional mutagenesis in 10 of the promonocytic leukemias that lacked c-myb alterations. Chromosomal
mapping studies, performed using progeny from interspecies backcross mice generated by mating (BALB/cAn 1 M. spret-
us)F1 females to BALB/cAN males, determined that Mml1 is located on the proximal end of mouse chromosome 10.
Interestingly, there were no recombinants between c-myb and Mml1 in 101 backcross progeny and Mml1 was mapped
approximately 20–25 kb upsteam of c-myb. Interestingly, c-myb mRNA and Myb protein are expressed at levels similar to
the levels observed in myeloid progenitor cells, but are not overexpressed. It is anticipated that future experiments will
determine whether Mml1 integration prevents down regulation of c-myb expression or activates another gene on chromo-
some 10. q 1996 Academic Press, Inc.
INTRODUCTION ies depending upon the particular virus used for induc-
tion. In the case of M-MuLV-induced MML in BALB/c
Leukemias with a promonocytic phenotype are in-
mice, 100% have undergone alterations at the c-myb lo-
duced in adult mice following intravenous inoculation of
cus (Shen-Ong and Wolff, 1987). With Ampho 4070A-in-
replication-competent retrovirus (Wolff et al., 1988).
duced MML (previously called AMPH-ML; Ref. 51), theThese are called MML for murine leukemia virus-induced
percentage varies depending upon the particular experi-myeloid leukemia. Previous studies have demonstrated
ment and ranges from 50 to 92% (Wolff et al., 1991, andthat Moloney murine leukemia virus (M-MuLV) and Am-
our own unpublished data). Activation of c-myb by FB29photropic virus 4070A (Ampho 4070A) cause disease
and F-MuLV, strain C57, occurs in 50 and 12%, respec-with a high incidence of 45–69% in BALB/cAn or DBA/
tively, of leukemias induced by these viruses (Mukhopad-2N mice, but only if the mice receive intraperitoneal injec-
hyaya and Wolff 1992; Nazarov et al., 1994). Therefore,tions of pristane (Wolff et al., 1988, 1991). Although the
although c-myb is often a target of insertional mutagene-role of pristane is not fully understood, it is believed to
sis in MML, there are many leukemias that show noindirectly promote leukemia through its induction of a
involvement of this locus. It has been demonstrated thatchronic inflammatory granuloma (Nason-Burchenal and
leukemias which lack c-myb rearrangements and haveWolff, 1992). Subsequently, it was shown that FB29
normal c-Myb RNA expression contain integrated provi-causes a similar disease in DBA/2 mice, albeit with a
ruses in their DNA. This raises the possibility that otherreduced incidence of 18% (Mukhopadhyaya and Wolff,
sites of integration may harbor genes that play a critical1992). Friend(F)-MuLV, strain C57, also induces pro-
role in MML transformation.monocytic leukemia, but only in immunocompromised or
Retroviral integration is essentially random with onlyirradiated mice (Mukhopadhyaya et al., 1994; Nazarov
some preference to genetic regions containing ex-and Wolff, 1995).
pressed genes (Rohdewohld et al., 1987; Scherdin et al.,The role of the retrovirus in some or all of these leuke-
1990). The finding of an integration site which is commonmias is to activate oncogenes by insertional mutagene-
to more than one independently derived leukemia sug-sis. It has been demonstrated that promonocytic leuke-
gests that the genetic aberration caused by the insertionmia can result from activation of the protooncogene c-
is oncogenic and facilitates clonal expansion. We setmyb; however, the percentage of leukemias that show
out to search, therefore, for a common site of proviralrearrangement of c-myb due to retroviral integration var-
integration in MML with the prospect that it might identify
a genetic region critical for neoplastic disease develop-1 To whom correspondence and reprint requests should be ad-
dressed. Fax: (301) 402-1031. E-mail: LWOLFF@helix.nih.gov. ment.
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Presented here is the identification of a new locus, Northern analysis
named Mml1, which is a common site of integration in
Total RNA was prepared using TRIzol ReagentMML induced by Ampho 4070A, FB29, and F-MuLV,
(GIBCO-BRL) according to instructions of the manufac-strain C57. This was accomplished through the cloning
turer and 2-mg samples were electrophoresed on 1.2%of cellular sequences residing adjacent to a single inte-
agarose gels containing formaldehyde (0.7%). RNAs weregrated provirus in an Ampho 4070A-induced leukemia
blotted onto HybondN (Amersham, Arlington Heights, IL),and the subsequent detection of rearrangements of the
UV cross-linked using a Stratalinker 1800 (Stratagene),locus in DNAs derived from several other leukemias.
and hybridized by standard techniques with 32P-labeled
probes (40).MATERIALS AND METHODS
Virus and cells Pulse field electrophoresis
Molecularly cloned Ampho 4070A (Chattopadhyaya et P1-5362 DNA (Genome Systems, Inc., St. Louis, MI)
al., 1981; Oliff et al., 1985) was propagated in NIH 3T3 was prepared using a plasmid preparation kit (Qiagen
cells maintained in Dulbecco’s modified Eagle medium Inc., Chatsworth, CA) with some modifications as follows:
containing 10% fetal calf serum. Viral stocks were pre- columns were washed in 750 mM NaCL, 50 mM MOPs,
pared from 24-hr supernatants. 15% ethanol, pH 7.5–7.6, and eluted with 1.4 M NaCl, 50
Leukemic cell lines were established in vitro from mM Tris–HCL, 15% ethanol, pH 8.1–8.2. After digestion
granuloma and/or ascites. Cells were seeded at 1 1 106 with restriction endonucleases, DNA was separated us-
or 2 1 106 cells/ml in Dulbecco’s modified Eagle medium ing a Bio-Rad CHEF-DR II system on a 1% agarose gel
supplemented with 10% fetal calf serum, 10% NCTC me- in 0.51 TBE buffer (0.045 M Tris-borate, 0.001 M EDTA,
dium (GIBCO-BRL Laboratories, Gaithersburg, MD), 5 1 pH 8.3).
1005 M 2-mercaptoethanol, nonessential amino acids, 1
mM sodium pyruvate, and 0.01 M N-2-hydroxyethylpiper- Probes
azine-N*-2-ethanesulfonic acid (HEPES). After cells were
A 28-base oligonucleotide probe, 5*-CAGAACTGA-established in culture, they were maintained in Dulbec-
GAATAGGGAAGTTCGGATC-3* (bp 212–239) derivedco’s modified Eagle medium supplemented with 10% fetal
from the Ampho 4070A LTR (Sambrook et al., 1989) wascalf serum. The murine myeloid leukemia cell line M1 has
used to screen for recombinant Lambda Zap II phage. Itbeen previously described (Selvakumaran et al., 1994).
was end labeled using terminal deoxynucleotidyl trans-
ferase according to Lueders et al. (1993).Animal experiments
Double-stranded probes under 1 kbp were labeled by
Female DBA/2N mice were obtained from the Freder- PCR amplification. For a 50-ml reaction 10–20 ng of pre-
ick Cancer Research Facility (Fort Detrick, Frederick, MD) amplified template, 5 ml of 101 PCR buffer (Perkin– El-
and were maintained in a specific pathogen-free animal mer, Foster City, CA) primers to a final concentration of
facility at the National Cancer Institute (Bethesda, MD). 1 mM, dATP, dTTP, and dGTP to final concentrations of
At 4 to 6 weeks of age, the mice were injected intraperito- 100 mM, dCTP to a final concentration of 5 mM, 150 mCi
neally with 0.5 ml of pristane (Aldrich Chemical Co., Mil- [32P]dCTP, and 2.5 U of Taq polymerase were combined.
waukee, WI). After 3 weeks, mice were inoculated intra- The Programmable Thermal Controller (M.J. Research,
venously with 0.5 ml undiluted cell culture supernatant Inc., Watertown, MA) protocol consisted of an initial 947
containing Ampho 4070A. Late-stage promonocytic dis- denaturation step for 2 min, followed by a three-step
ease was monitored by preparing smears of peritoneal cycle repeated 10 times and including a 947 denaturation
ascites cells. Cells were stained with Diff-Quik (American step for 1 min, 557 annealing step for 1 min, and a 727
Scientific Products, McGaw Park, IL). Tumors were sus- elongation step for 3 min. The program concluded with
tained by peritoneal transplantation in pristane-treated a 727 elongation for 10 min and cooling to 47. A NheI –
DBA/2N mice. BssHII fragment of the 4070A LTR, which was cloned in
Bluescript II SK0 was amplified using a sense primerSouthern analysis
(5*-CTAGCTTAAGTAACGCCA-3*) (bp 168 to 186) and
antisense primer (5*-GCGAGAAGCGAGCTGATTG-3*)Genomic DNA was prepared from primary peritoneal
tumors as previously described (Wolff et al., 1988). Ten- (bp 433 to 451)(Sorge et al., 1986). For labeling Mml1
probes, pK29, p56A (see Fig. 2), primer pairs (5*-GAA-microgram samples were digested to completion with
restriction endonucleases, electrophoresed through hori- CAGTGTGGTGTGCAAGTGTC-3*) and (5*-GTCAACATA-
GAGATAGTATG or GCTTGTCTCTGCTCAGAGCTC-3*)zontal agarose gels, and blotted onto nylon membranes.
A Stratalinker 1800 (Stratagene, La Jolla, CA) was used and (5*-GGTTTGCCAAGTTCCTGG-3*), respectively, were
used. Primers derived from plasmid sequences wereto UV cross-link DNA to the membranes which were then
hybridized with 32P-labeled DNA probes. also used in preparing probes for some experiments;
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these primers were used for labeling the above Mml1 PCR analysis of proviral integrations
probes pK29, p56A, and p55B. Oligonucleotides used in
A PCR analysis for the determination of the provirusPCR labeling and end labeling were synthesized on an
orientation within the Mml1 locus was carried out onApplied Biosystems model 381A or acquired from com-
tumor cell DNA using a combination of Mml1 primersmercial sources (Bioserve, Laurel, MD).
and primers derived from the viral LTR sequences. ADouble-stranded DNA probes larger than 1 kbp, for
reaction mixture, with a total volume of 100 ml and con-example, Mml1 p38, a full-length c-myb cDNA probe (Be-
sisting of 200 ng of genomic DNA in H2O, 11 PCR buffernder and Kuehl, 1986) and 5*AMyb (EcoRI to BamHI up-
(Perkin–Elmer), oligonucleotide primers at a concentra-stream of exon 1) were labeled by random priming or
tion of 1 mM, and each dNTP at a concentration of 200nick translation using kits from GIBCO-BRL.
mM, was heated at 957 for 5 min and then cooled and
held at 587 for 5 min or more. A hot start was performedCloning genomic DNA fragments
by adding 1 U of Perfect Match (Stratagene) and 2.5 U
In order to clone a LTR– Mml1 junction fragment from
of Taq polymerase to each reaction and followed by a
the genomic DNA of tumor 30-4-18, DNA was digested
30 cycle program consisting of 727 for 2 min, 957 for 1
with NheI and size fractionated on an agarose gel. DNA
min, and 557 for 3 min. A final incubation at 727 for 10
of 0.9 to 1.2 kbp was purified and ligated into the XbaI
min and cooling to 47 concluded the protocol. Oligonucle-
cloning site of a lambda ZapII (Stratagene) and packaged
otides from the Mml1 were determined by sequencing
using the Gigapack II Gold packaging system (Stra-
and their locations are depicted in Fig. 2: #1, sense
tagene). Five hundred thousand plaques were trans-
(5*-GAACAGTGTGGTGTGCAAGTGTC-3*); #2, antisense
ferred to nylon membranes (Nytran, Schleicher and
(5*-GACACTTGCACACCACACTGTTC-3*); #3 sense (5*-
Schuell, Inc., Keene, NH) and screened by hybridization
ACCATGAGCTATGACAACATAG-3*); #4, antisense (5*-
using an end-labeled oligonucleotide probe derived from
GCTCTAGAACTAGTGTGCATC-3*). Viral LTR-derived oli-
the U3 region of Ampho 4070A LTR (see oligonucleo-
gonucleotide sequences used in this analysis were as
tides, below). Nine positive clones were picked. One was
follows: Ampho 4070A sense (5*-CAGAACTGAGAATAG-
chosen for further analyses and its insert was subse-
GGAGTTCGGATC-3*) (bp 212–239) (Sorge et al., 1984);
quently cloned into pBluescript II SK0 (Stratagene). For
Ampho 4070A antisense (5*-GATCCGAACTTCCCTATT-
cloning a larger 12-kbp fragment of DNA from normal
CTCAGTTCTG-3*) (bp 212–239) (Sorge et al., 1984); Fr-
DBA/2 liver, DNA was digested with EcoRI, size fraction-
MuLV, strain C57, sense (5*-GAGTGATTGACTACCCGT-
ated, and ligated into EMBL 4. Five hundred thousand
CTC-3*) (bp 110–130) (Koch et al., 1984); Fr-MuLV, strain
recombinant clones were screened using labeled pK29
C57, antisense (5*-CTGCAGCTATCAGGCTAAGC-3*) (bp
as a probe. Mml1 sequences isolated from one recombi-
7863–7882) (Koch et al., 1984); FB29 sense (5*-CAGAGT-
nant phage preparation were subsequently cloned in
GATTGACTACCCG-3*) (bp 108–130) (Perryman et al.,
pBluescript II SK0.
1992); FB29 antisense (5*-CTGCGGCTATCAGGCTAAGC-
3*) (bp 7863–7882) (Perryman et al., 1992).DNA sequencing
The Sanger method for double-stranded DNA se-
Metabolic labeling of protein, immune precipitation,
quencing was employed using reagents and protocols
and gel electrophoresis
provided by Amersham Life Science Inc. (Arlington
Heights, IL). To detect c-Myb protein, approximately 1.5 1 107 cells
were starved for 15 min in 1 ml of methionine-free me-
Chromosomal mapping studies
dium and then metabolically labeled for 1 hr with 500
mCi Trans[35S] label (ICN Biochemicals, Irvine, CA). CellsInbred and wild mouse strains as well as 84 backcross
progeny from the interspecific cross (BALB/cAn 1 M. were disrupted in cold lysis buffer containing 20 mM
Tris-chloride (pH 7.5), 0.05 M NaCl, 0.5% Nonidet P-40,spretus)F11 BALB/cAn were bred and maintained under
NCI Contract NO1-CB-21075 at PerImmune (Rockville, 0.5% SDS, 0.5% sodium deoxycholate and 10 mM iodo-
acetamide with the following inhibitors: 50 mg of aproti-MD). DNA isolations and hybridizations of Southern blots
were performed as described previously (Mock et al., nin/ml, 50 mg leupeptin/ml, 10 mg pepstatin/ml, 1 mM
phenylmethylsulfonyl fluoride. Lysates were sonicated,1987). Polymerase chain reaction (PCR) typings of simple
sequence length polymorphisms (SSLP) were also per- precleared by incubation with preimmune rabbit serum
and Staphylococcus aureus (Cowan I strain) for 15 minformed as previously described (Mock et al., 1993). Maxi-
mum likelihood estimates of recombination probabilities, followed by centrifugation (30,000 g), and immunoprecipi-
tated with rabbit antiserum raised against the bacterialtheir variances, and standard errors among backcross
progeny were calculated according to Green (1981). fusion proteins GST-c-Myb(I) (Bies et al., 1996). All precip-
itates were electrophoresed under reducing conditionsGene order was determined by minimization of recombi-
nation events across the chromosome. on a 7% polyacrylamide gel and visualized by autoradiog-
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FIG. 1. Southern blot hybridization demonstrating clonal proviral integrations in ‘‘non-myb’’ tumors induced by Ampho 4070A in DBA/2 mice. DNA
was digested with EcoRI and probed with a NheI to BssHII fragment from the Ampho 4070A LTR. Panels represent two different experiments where
hybridization to background bands varied. EcoRI cuts one time within intact Ampho 4070A; however, in instances where only one Ampho 4070A-
specific band is found, this site was probably deleted. DNA size markers are in kbp.
raphy. Loading was adjusted according to the TCA-pre- DNA of this tumor using the LTR probe described above.
A partial genomic library was prepared in lambda Zap II,cipitable 35S counts in total lysates.
using NheI-digested, size-selected DNA, and a recombi-
nant clone containing Ampho 4070A sequences wasRESULTS
identified and isolated. This cloned DNA was subcloned
Proviral integration sites in promonocytic leukemias into a plasmid vector, which was called pK26. Subse-
quently, a 12-kbp EcoRI fragment from this genomic re-A subset of promonocytic leukemias (MMLs) induced
gion of DNA, which we called Mml1, was cloned in EMBLby Ampho 4070A in DBA/2 mice were demonstrated to
4. For screening recombinant phage, we employed as alack c-myb rearrangements. Several c-myb probes, A, B,
probe a subcloned 400-bp XbaI to NheI segment (pK29)C, and D (depicted in Nazarov et al., 1994), which have
derived from the cellular flanking sequences in pK26.been reported previously to detect alterations due to pro-
With the use of two probes, pK29 and p55B, from Mml1viral insertion (Shen-Ong and Wolff, 1987; Wolff et al.,
(see Fig. 2) it was possible to identify 6 additional Ampho1991; Nazarov et al., 1994), were unable to detect rear-
4070A-induced MMLs with integrations in this locus. Ex-rangements in any part of the locus. Although these
amples of tumor-specific fragments in the DNA of 4 ofDNAs lacked c-myb rearrangements, they were demon-
the additional tumors and the original 30-4-18 are shownstrated to harbor integrated proviruses. As shown in Fig.
in Fig. 3. Promonocytic leukemias of DBA/2 mice induced1, virus-specific EcoRI fragments can be identified in
by other retroviruses were also examined for rearrange-each tumor DNA using a NheI–BssHII, 294-bp probe
ments at this locus and it was found that 1 leukemiaderived from the U3 region of the Ampho 4070A LTR. A
induced by FB29 virus (Mukhopadhyaya and Wolff, 1992),majority of these tumors have only one virus-specific
R3-16-59, and 2 leukemias induced by F-MuLV, strainband, demonstrating the presence of only one provirus
C57 (Nazarov et al., 1994), V46-33 and V46-34, had rear-in the tumor DNA. The presence of these integrations
rangements as well (data not shown). A total of 10 leuke-suggests that other sites in the cellular genome, in addi-
mias, therefore, were determined to have proviral inser-tion to the c-myb locus, may be activated and contribute
tion sites in the Mml1 locus. This represents 12% (7 ofto transformation in these leukemias.
60 tumors) of the Ampho 4070A-induced leukemias and
12 (1 of 8) and 22% (2 of 9) of the FB29 and F-MuLV,Cloning of a proviral-cellular junction fragment and
strain C57-induced leukemias, respectively.identification of a common site of integration
A map of the cloned region of Mml1 was prepared
following a restriction enzyme analysis of normal DBA/2A tumor, 30-4-18, with a single provirus was chosen
liver DNA and tumor DNAs, and the positions of integra-for cloning an integration site. A 1.0-kb NheI fragment
tion sites within it were determined, as depicted in Fig.containing LTR sequences and presumed to contain 470
bp of flanking cellular sequences was identified in the 2. The locations of several of the provirus integration
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FIG. 2. Restriction map of Mml1 locus showing locations of integrated proviruses. Orientation of proviral elements indicated by arrowheads.
Numbers within circles represent oligonucleotide primers utilized in PCR analysis of integration sites. (/) sense orientation; (0) antisense orientation.
Probes used in this report are designated as bars below the map. B, BamHI; Bg, BglII; E, EcoRI; H, HindIII; M, MscI; N, NheI; S, SstI; Sp, SpeI.
sites were confirmed and their orientation was deter- ruses, HindIII-digested tumor DNA and normal liver DNA
were hybridized with either p38 or pK29 and p56A. Inmined by a PCR analysis. As shown in Fig. 4, primers
from the LTR were used in the PCR analysis in combina- instances where one viral fragment was observed, which
was larger than the normal fragment, the size of thetion with Mml1 primers and unequivocal results as to
orientation were obtained for each of the tumors. In order provirus was equivalent to the difference in size of the
two fragments (see Table 1). When two viral-specific frag-to determine the approximate size of the integrated provi-
FIG. 3. Southern blot hybridizations of DNA from 5 tumors and normal tissue showing rearrangements of the Mml1 locus. The probe was derived
from Mml1 sequences adjacent to the Ampho 4070A 3* LTR in 30-4-18 (pK29; XbaI–NheI; see Fig. 2). Three different restriction enzymes were used
and are indicated below each panel.
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FIG. 4. PCR analysis for determination of provirus orientation. DNAs from tumors or liver, as a control, were used as templates for PCR reactions.
Primers were from the virus LTRs as described under Materials and Methods and were used in combination with primers derived from the Mml1
locus (see Fig. 2).
ments were obtained, as in the case of V46-33, the size distribution patterns were linked to those of two other
PCR SSLP markers, D10Mit28 and D10Mit15. Based onof the provirus was determined to be approximately the
these analyses, Mml1 was mapped to a position approxi-sum of the two fragments. Since there are two HindIII
mately 8.3 cM distal to D10Mit28 (Fig. 5). Comparisonssites in Ampho 4070A and F-MuLV, which are 2 and 4
with a consensus map of mouse Chr 10 (Taylor et al.,kbp apart, respectively, the size of the provirus could be
1994) revealed that Myb was also within this region ofas much as 2 to 4 kbp larger than our estimate. It was
the chromosome. As a result, we utilized the 6.0-kb PstIpossible to determine from this analysis that all of the
fragment in BALB/cAn and a 3.9-kb fragment in M.proviruses, with the exception of perhaps V46-33, were
spretus, which hybridized to Myb in order to positiondeleted.
Myb with respect to Mml1. Surprisingly, there were no
recombinants between the two loci in 101 progeny, sug-Chromosomal localization of the Mml1 locus in the
gesting that the two loci are located within 3 cM of eachmouse
other. To determine if Mml1 overlapped with the c-Myb
To determine the map location of Mml1, genomic locus, we carried out Southern blot analysis of a 40-kb
DNAs from inbred and wild mice were examined by region encompassing Mml1 to determine if either the 5*
Southern analysis for polymorphisms in restriction frag- or 3* ends of the Myb locus hybridized to Mml1. We were
ments that hybridized to Mml1. The Mml1 probe recog- unable to detect any overlap of the two loci using this
nized a 1.7-kb HaeIII fragment in BALB/cAnPt and a 2.25- approach. Subsequently, we obtained a P1 clone (#5362)
kb fragment in M. spretus. As a result the probe was that overlapped both the c-myb locus and Mml1 and,
hybridized to a panel of HaeIII-digested DNAs from a using a CHEF-DR II system for separation of digested
fragments of the clone, it was possible to determine thatseries of 84 interspecific backcross progeny. The allele
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TABLE 1 show that mRNA and protein from leukemias with Mml1
rearrangements are of normal size and are not overtlySize Determination of Proviruses Integrated in Mml1
overexpressed compared to the M1 cell line.
Size of normal Size of virus-specific Total size
liver fragmentsa fragmentsa of virus DISCUSSION
Tumor Probe (kbp) (kbp) (kbp)
It is evident from studies of leukemia in animal models
30A-2-6 p55B 0.8 1.2 0.4 that the unique properties of retroviruses can lead to the
V46-34 p55B 0.8 4.0 3.2
identification of genes involved in growth control (re-30C-19 pK38 5.6 6.6 1.4
viewed in Kung et al., 1991; Tsichlis and Lazo, 1991;30-3-14 pK38 5.6 6.3 0.7
Athas et al., 1994; Jonkers and Berns, 1996). The presentR3-16-59 pK38 5.6 6.3 0.7
V46-33 pK38 5.6 5.2 ⁄4.9 study identifies a locus, Mml1, on mouse chromosome
5.3 10, that is important to the development of MML disease,
30C-18 p56A 5.6 2.4 ⁄1.6
pK29 5.6 4.8
30C-13 p56A 5.6 9.4b 3.8
pK29
30-4-18 p56A 5.6 6.4b 0.9
pK29
30C-23 p56A 5.6 7.6b 2.1
pK29
a DNAs were digested with HindIII and hybridized with probes as
shown.
b The same size fragment was obtained for both probes.
the integration sites were located between 19 and 27 kb
upstream of the c-myb locus (Fig 8). For this experiment
we used a myb probe from a region just 5* of exon 1
and distances of the virus integration sites were mapped
relative to a SstII site about 1.5 kb downstream of exon
1. Using this 5* myb probe and the pK29 probe from
Mml1, linkage was detected on three fragments, the
smallest of which was 27 kb (SstII/KpnI). Separate frag-
ments of 19 and 21 kb (SstII/BssHI) were detected by
the two different probes.
Myb expression in leukemias with Mml1
rearrangements
An examination of c-Myb mRNA and protein expres-
sion in established leukemic cell lines was undertaken
to determine its involvement in the genesis of the leuke-
mias. This was particularly important because of the
close proximity of the two loci on chromosome 10 and
the fact that c-Myb is activated in other promonocytic FIG. 5. Location of Mml1 locus on mouse Chr 10. The positions of
markers along Chr 10 were taken from the Chr 10 report (Taylor et al.,leukemias. c-Myb expression in the myeloblastic leuke-
1994) except for the positions of markers determined in the currentmia cell line, M1, is shown in lane 1 of Figs. 6 and 7.
study. The haplotypes of 84 backcross progeny are given in the tableExpression of c-Myb in leukemias with Mml1 rearrange-
below the chromosome map. The loci followed in the cross are indi-
ments are shown in lanes 2 through 4 and typical expres- cated on the left. Each column represents the chromosome inherited
sion of c-Myb from rearranged loci is demonstrated in in the backcross progeny; the number of progeny exhibiting each type
of chromosome is listed at the bottom. The black squares representlanes 5 through 9. Leukemia R-4-11, in lane 4, has an
the M. spretus allele and the open squares represent the BALB/cAnintegration in exon 9 of c-myb which results in truncation
allele. Recombination fractions (the number of recombinants betweenof both the mRNA and protein at the carboxyl terminus;
markers/total number of progeny) and distances between markers (plus
the other leukemias, in lanes 5–8, have integrations in or minus standard errors) in centiMorgans (cM) are indicated. D10mit15
intron 3 of c-myb and produce a larger transcript which is a microsatellite which amplifies part of the simple quadruplet repeat
sequence 3 (Sgr3).is driven by the retrovirus LTR. The results of this study
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FIG. 6. Northern blot analysis of c-Myb expression in the leukemias
with Mml1 rearrangements. The probe was full length c-myb cDNA.
Total RNA in lane 1 is from the myeloblast cell line, M1. Total RNA
samples in lanes 2–4 are from leukemic cell lines with Mml1 rearrange-
ments (30A-2-6, 30-3-14, and 30-4-18, respectively). Samples in lanes
5– 9 are from Ampho 4070A-induced tumors with c-myb rearrange-
ments (R-4-11, 30A-1-2, 30A-1-2, 30A-3-12, 30A-3-14, 3-A 6-26, respec-
tively). Probes, used to hybridize the same blot, are indicated on the
right.
since 10 separate promonocytic leukemias were demon-
strated to have viral integrations at this locus. Although
the protooncogene c-myb was previously implicated in
the development of a large percentage of MML, to date
we have not found any leukemias in which both c-myb
and Mml1 loci are targets of mutagenesis. This may sug-
FIG. 8. Analysis of P1-5362 digested DNA using Mml1 and c-myb
probes. (A) P1-5362 DNA was digested with SstI (lane 1) or double
digested with SstII and BssHII (lane 2), KpnI (lane 3), or SmaI (lane
4) and separated on a 1% agarose gel using a CHEF-DR II system.
Electrophoresis was for 12 hr at 8 V/cm with the switch time ramped
from 0.5 to 5 sec followed by a run for 12.5 hr at 16 V/cm with the
switch time ramped from 0.2 to 2 sec. DNA was transferred to a nylon
membrane and hybridized with a 32P-labeled pk29 probe. DNA stan-
dards (5-kb ladder, Bio-Rad) are shown to the right of the panel. (B)
Identical blot as in A, hybridized with 5*A myb probe. (C) Map of region
on chromosome 10 linking Mml1 and c-myb. The distance in kilobases
is depicted above the map. Designated fragments of 37, 27, and 19 kb
represent hybridizing bands in A and B above. B, BssHII; K, KpnI; S,
SmaI; S, SstII.
gest that oncogenic activations at these loci are not co-
operative as has been observed for some common inte-
gration sites in other retrovirus-induced neoplasms (Van
Lohuizen et al., 1989; Ben-David and Bernstein, 1991;
Levy et al., 1993). Integration within Mml1 is observed in
DNA from primary tumors and, therefore, would not be
FIG. 7. Immune precipitation of c-Myb protein in leukemic cell lines.
considered to be a progression event associated with inCell lines derived from transplanted tumors were labeled with
vivo transplantation or in vitro culturing of cells as is the[35S]methionine, immune precipitated with polyclonal antiserum di-
rected toward cMyb, and separated under reducing conditions on a case for some sites of proviral insertion sites associated
7% polyacrylamide gel. lanes 1 – 3 are leukemias with Mml1 rearrange- with both myeloid and lymphoid neoplasms (Bear et al.,
ments (30A-2-6, 30-3-14, and 30-4-18, respectively). Samples in lanes 1989; Gilks et al., 1993; Patriotis et al., 1993).
4–8 are from Ampho 4070A-induced tumors with c-myb rearrange-
It has not been determined whether integration withinments (R-4-11, 30A-1-2, 30A-1-2, 30A-3-12, 30A-3-14, 3-A 6-26, respec-
Mml1 occurs at early or late stages of disease develop-tively). RNA in lane 9 is from the myeloblast cell line, M1. Loading was
adjusted according to the TCA-precipitable 35S counts in total lysates. ment which takes a total of 3 months to complete. In the
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case of c-myb activation, data suggests that insertion tegrations, only one provirus has been demonstrated to
be integrated per tumor (see Fig. 1 which shows singleinto the locus and activation of altered mRNA expression
occurs as early as 2 to 3 weeks in hematopoietic tissues proviral integrations in 30-4-18, 30C-23, 30C-18, and 30C-
19). In addition, we have not observed rearrangementssuch as the bone marrow and spleen (Nason-Burchenal
and Wolff, 1993). Interestingly, for MMLs involving either in both alleles in any leukemias. However, we cannot
rule out the possibility that mutations may occur on onegenetic locus, the latency for disease is approximately
the same and both types of MML require an inflammatory allele complementing proviral insertion on the other al-
lele.granuloma for full development. We propose that the in-
flammatory granuloma may provide growth promoting Several features of the proviral integrations in Mml1
have been observed. First, the integrations appear to beand mutagenic stimuli as well as an immunosuppressive
environment (Wolff et al., 1988; Nason-Burchenal and clustered in three regions within the locus. Presently, we
do not know whether this is due to an optimal positioningWolff, 1992).
So far we have been unable to demonstrate a direct required for activation of a close or distant gene or simply
to some integration site preferences within the locuscorrelation between proviral insertion into Mml1 and ex-
pression of c-myb, even though our data indicate that (Craigie, 1992; Milot et al., 1994). Second, proviruses
were orientated in both directions. This suggests thatthese two loci are in close proximity on chromosome 10.
It was demonstrated in this study that Myb mRNA and the integration is not providing promotor insertion. How-
ever, it could be providing enhancer function since en-protein from leukemias with Mml1 rearrangements are
not overexpressed compared to the myeloblastic cell line hancers can work in either direction and from either the
3* or 5* end of a gene or even at a distance (Kung et al.,M1. However, it is important to note that c-Myb expres-
sion is normally downregulated during differentiation (re- 1991). Finally, most or all of the proviruses have under-
gone deletion to varying degrees. Provirus deletion wasviewed in Luscher and Eisenman, 1990, and Introna et
al., 1994) and is not expressed in other monocytic tumor observed previously for viruses integrated in the c-myb
locus in MML as well. An explanation for such deletionscell lines (Baumbach et al., 1987). We cannot, therefore,
rule out the possibility that integration in Mml1 directly or may be escape from the immune response through loss
of viral-encoded cell surface protein expression.indirectly inhibits the downregulation of c-myb normally
associated with terminal differentiation. Interestingly, two common integration sites, Ahi-1 and
Mis-2, identified in Abelson murine leukemia virus-in-We have also searched for new a gene within the
Mml1 locus, but have not been able to detect a transcript duced pre-B lymphomas and Mo-MuLV-induced rat T-
cell leukemias, respectively, also map close to c-mybusing probes derived from a 23-kb region encompassing
the new sites of integration (unpublished data). Although (Poirer et al., 1988; Villeneuve et al., 1993). Using long
range mapping techniques, it was determined that Mis-a gene encoded by this immediate region may still be
identified, it is also possible that integration into this 2 is located approximately 160 kbp downstream of c-myb
and that Ahi-1 is about 35 kbp downstream from c-myblocus activates a distant gene. There are several exam-
ples of long range activation, including activation of c- (Villeneuve et al., 1993; Jiang et al., 1994).
It will be of interest to determine in future studiesmyc by provirus insertion in Mlvi-4 and by Mlvi-1/mis-1/
pvt-1 loci, located 30 and 270 kb 3* of c-myc, respectively whether Mml1 integration prevents the down regulation
of c-Myb or whether another gene is affected by integra-(Lazo et al., 1990), activation of Evi-1 by integrations in
Cb-1/fim-3, located 90 kb 5* to the gene (Bartholomew tion at this locus. Since the integration is approximately
20–25 kb upstream from c-myb, both mechanisms areand Ihle, 1991), and activation of cyclin D1(cyl-1) by inte-
grations 50–300 kb away in fis-1 (Lammie et al., 1992). possible.
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